U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06906237) titled 'Scarless Advanced Breast Extended Oncoplasty: The ScarABEO Study' on March 07.
Brief Summary: Breast conserving surgery followed by radiotherapy is the gold standard treatment for early breast cancer. Cases with unfavorable tumor volume to breast volume ratio or challenging localizations are at higher risk of margin infiltration or poor aesthetic outcomes. While margin infiltration represents one of the strongest predictors of local recurrence, unappealing cosmetic results may significantly impair survivors' quality of life. Over the past two decades, the adoption of oncoplastic breast conserving surgery (OBCS) techniques has shown ...